This consortium represents a multi-disciplinary team effort to launch an integrated program focused on model development/refinement, cancer gene discovery, preclinical experimental therapeutics and technology development. The model development initiative will seek to develop and characterize models that recapitulate two fundamental aspects of cancer in humans - epithelial cancer predisposition and episodic chromosomal instability - by engineering mice that experience transient telomere dysfunction and subsequent telomerase activation in the evolution of colorectal cancer and squamous cell carcinoma of the skin. In addition, a model of pancreatic ductal adenocarcinoma will be developed in which we attempt to ascertain whether telomere-linked chromosomal instability and compromised telomere checkpoints serve as a general mechanisms driving age-dependent epithelial carcinogenesis. In the cancer gene discovery area, we will conduct a comprehensive comparative oncogenomic analysis of human and mouse epithelial cancers (specifically colon, skin and pancreas) by taking advantage of powerful gene-specific array-CGH and informatics platforms. These comparative oncogenomic studies will not only serve to validate these models but also carry the potential to identify common and distinct molecular themes in human and murine carcinoma development. In therapeutics program, inducible oncogene melanoma models will be used to identify genetic resistance elements capable of replacing activated RAS, BRAF or AKT function in established tumors. Both genomic and forward genetic screens are proposed. Finally, an important mission will be technology development in the areas of genomics, informatics, imaging and nanoteclmology. Specifically, the team will develop the oligo-based CGH platform and develop of informatics tools for crossspecies genomic comparisons. The imaging component will feature several experiments such as the application of novel reagents to visualize the dynamic vascular changes occurring in regressing tumors as well as hypoxia-induced reporters capable to monitoring oxygen status in growing and regressing tumors. Finally, nanosensors will be developed that are capable to detecting telomerase activity and quantifying telomere reserves.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
2U01CA084313-06
Application #
6734489
Study Section
Special Emphasis Panel (ZCA1-SRRB-U (J1))
Program Officer
Marks, Cheryl L
Project Start
1999-09-30
Project End
2009-03-31
Budget Start
2004-09-27
Budget End
2005-03-31
Support Year
6
Fiscal Year
2004
Total Cost
$679,466
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Wardwell-Ozgo, J; Dogruluk, T; Gifford, A et al. (2014) HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome. Oncogene 33:1017-26
Kapoor, Avnish; Yao, Wantong; Ying, Haoqiang et al. (2014) Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell 158:185-197
Hu, Jian; Ho, Allen L; Yuan, Liang et al. (2013) From the Cover: Neutralization of terminal differentiation in gliomagenesis. Proc Natl Acad Sci U S A 110:14520-7
Dunn, Gavin P; Rinne, Mikael L; Wykosky, Jill et al. (2012) Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev 26:756-84
Scott, Kenneth L; Nogueira, Cristina; Heffernan, Timothy P et al. (2011) Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell 20:92-103
Ding, Zhihu; Wu, Chang-Jiun; Chu, Gerald C et al. (2011) SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 470:269-73
Nogueira, C; Kim, K-H; Sung, H et al. (2010) Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis. Oncogene 29:6222-32
Sahin, Ergün; Depinho, Ronald A (2010) Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 464:520-8
Kabbarah, Omar; Nogueira, Cristina; Feng, Bin et al. (2010) Integrative genome comparison of primary and metastatic melanomas. PLoS One 5:e10770
Zheng, Bin; Jeong, Joseph H; Asara, John M et al. (2009) Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. Mol Cell 33:237-47

Showing the most recent 10 out of 51 publications